List of Turning Point Therapeutics patents

Patent 11286264 was granted and assigned to Turning Point Therapeutics on March, 2022 by the United States Patent and Trademark Office.

Patent 11291667 was granted and assigned to Turning Point Therapeutics on April, 2022 by the United States Patent and Trademark Office.

Patent 11155563 was granted and assigned to Turning Point Therapeutics on October, 2021 by the United States Patent and Trademark Office.

Patent 11286265 was granted and assigned to Turning Point Therapeutics on March, 2022 by the United States Patent and Trademark Office.

Patent 11634433 was granted and assigned to Turning Point Therapeutics on April, 2023 by the United States Patent and Trademark Office.

Patent 11142533 was granted and assigned to Turning Point Therapeutics on October, 2021 by the United States Patent and Trademark Office.

Patent 10689400 was granted and assigned to Turning Point Therapeutics on June, 2020 by the United States Patent and Trademark Office.

Patent 10745416 was granted and assigned to Turning Point Therapeutics on August, 2020 by the United States Patent and Trademark Office.

Patent 11008337 was granted and assigned to Turning Point Therapeutics on May, 2021 by the United States Patent and Trademark Office.

Patent 10618912 was granted and assigned to Turning Point Therapeutics on April, 2020 by the United States Patent and Trademark Office.

Patent 11981684 was granted and assigned to Turning Point Therapeutics on May, 2024 by the United States Patent and Trademark Office.